Schedule 13D ownership disclosure

BIOPHARMX CORP

Security class unavailable · CUSIP: 09072X309

Event date: 2020-01-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-20-000079
Form type
SC 13D
Filer
BioPharmX Corp
CIK
CIK 1504167
Filed
Jan 30, 2020
Reporting period
Jan 28, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub